Malvern medical-device company Orthovita Inc. said today that it has received clearance to market a new treatment for spinal fractures.

The fast-track 510(k) clearance was issued by the U.S. Food and Drug Administration for Cortoss, an injectable material that mimics the properties of human cortical bone, the outer layer of bone. That clearance is designed for devices that are basically equivalent to something already on the market.

The composite has a paste-like consistency that gets injected into the fracture site.